Open AccessApatinib as first-line treatment in patients with advanced hepatocellular carcinoma: a phase II clinical trial
Author(s) -
Zhenyu Hou,
Keyun Zhu,
Xuejiao Yang,
Ping Chen,
Wei Zhang,
Yunlong Cui,
Xiaolin Zhu,
Tianqiang Song,
Qiang Li,
Huikai Li,
Ti Zhang
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-20-2990
Subject(s) - apatinib , medicine , clinical endpoint , adverse effect , hepatocellular carcinoma , toxicity , oncology , gastroenterology , clinical trial , phases of clinical research , response evaluation criteria in solid tumors , progression free survival , surgery , cancer , overall survival
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom